Infectious Diseases

The Pediatric Infectious Diseases division assists in the diagnosis and management of children with a variety of known or suspected infections as well as immune deficiencies. Children are commonly referred for outpatient evaluation of recurrent or prolonged infections, persistent fever, suspected immune deficiency, enlarged lymph nodes, pneumonia, and a wide range of childhood infections. We also treat and manage children with chronic infections such as HIV, Hepatitis B Virus, and Hepatitis C Virus. Additionally, our providers engage in laboratory research of infectious disease mechanisms and development of vaccines to improve future options for prevention and treatment of children and adults.

Find a Doc

My UNC Chart

Contact Us

Make a Gift

INFECTIOUS DISEASES NEWS

View all News

• 

  Collazo-Roman Receives Stanley A. Plotkin Award by Pediatric Infectious Diseases Society

  The Pediatric Infectious Diseases Society (PIDS) has named Dr. Marielys Collazo-Roman, Pediatric Infectious Diseases Fellow at the University of North Carolina at Chapel Hill, the recipient of its 2025 Stanley A. Plotkin Lectureship Award.

• 

  Vogt Honored with 2025 Young Investigator Award by Pediatric Infectious Diseases Society

  The Pediatric Infectious Diseases Society (PIDS) has named Dr. Matthew Vogt, Assistant Professor of Pediatrics (Infectious Diseases) and Microbiology & Immunology at the University of North Carolina at Chapel Hill, the recipient of its prestigious 2025 Young Investigator Award.

• 

  Allison & Vogt: 2025-26 Jefferson-Pilot and James Woods Recipients

  Bianca Allison, MD, MSHP, Associate Professor of Pediatrics, has been awarded the 2025-26 Jefferson-Pilot Fellowship in Academic Medicine and Matthew Vogt, MD, PhD, Assistant Professor of Pediatrics and Microbiology & Immunology has received a James W. Woods Junior Faculty Award. Congratulations!

• 

  Novel Immunologic Surveillance Study Provides New Insights Into Post-Pandemic Return of Respiratory Viruses

  Ongoing clinical research study in US children documents the rebound of endemic respiratory viruses, builds foundation for expediting future vaccines and treatments.